Regencell Bioscience Holdings Limited Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
Regencell Bioscience Holdings Limited (RGC) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations of 275.33 thousand shares for the 12-month period ending 2022-06-30, per its 20-F filed 2022-10-31.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations · last filed 2022-10-31
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations 12 month |
|---|---|
| 2022-06-30 | 275.33K shares 20-F · filed 2022-10-31 |